HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Li Selected Research

Toll-Like Receptor 7

4/2022Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy.
1/2018Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
1/2018Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells.
6/2015Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Li Research Topics

Disease

1195Neoplasms (Cancer)
12/2022 - 01/2002
289Inflammation (Inflammations)
11/2022 - 01/2002
242Infections
12/2022 - 01/2002
217Breast Neoplasms (Breast Cancer)
11/2022 - 03/2002
193Neoplasm Metastasis (Metastasis)
07/2022 - 03/2002
139Carcinogenesis
12/2022 - 05/2002
131Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 11/2002
109Hepatocellular Carcinoma (Hepatoma)
07/2022 - 01/2003
104Pain (Aches)
04/2022 - 04/2002
101Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 07/2003
92Carcinoma (Carcinomatosis)
01/2022 - 03/2002
90Fibrosis (Cirrhosis)
06/2022 - 05/2004
86Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 11/2003
82Hypoxia (Hypoxemia)
08/2022 - 05/2003
75Hypertension (High Blood Pressure)
06/2022 - 01/2005
74Lung Neoplasms (Lung Cancer)
06/2022 - 04/2005
70COVID-19
12/2022 - 01/2020
70Stomach Neoplasms (Stomach Cancer)
02/2022 - 03/2002
69Wounds and Injuries (Trauma)
09/2022 - 01/2005
61Type 2 Diabetes Mellitus (MODY)
12/2022 - 05/2002
61Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 03/2004
60Nasopharyngeal Carcinoma
05/2022 - 04/2006
58Obesity
05/2022 - 05/2005
55Body Weight (Weight, Body)
01/2022 - 01/2006
54Insulin Resistance
08/2022 - 05/2002
53Atherosclerosis
09/2022 - 02/2002
52Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 02/2006
50Necrosis
05/2022 - 03/2002
50Colonic Neoplasms (Colon Cancer)
01/2022 - 02/2008
49Myocardial Infarction
01/2022 - 04/2002
45Ischemia
01/2021 - 11/2003
42Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2022 - 07/2003
42Leukemia
12/2021 - 07/2003
41Sepsis (Septicemia)
03/2022 - 08/2010
41Prostatic Neoplasms (Prostate Cancer)
03/2022 - 10/2003
41Reperfusion Injury
03/2022 - 04/2002
41Glioma (Gliomas)
01/2022 - 05/2002
40Alzheimer Disease (Alzheimer's Disease)
05/2022 - 01/2005
39Hemorrhage
09/2022 - 04/2002
39Liver Neoplasms (Liver Cancer)
05/2022 - 07/2002
38Stroke (Strokes)
05/2022 - 12/2002
38Hepatitis B
01/2022 - 09/2002
38Asthma (Bronchial Asthma)
01/2022 - 01/2002
36Disease Progression
01/2022 - 01/2006
33Ovarian Epithelial Carcinoma
01/2022 - 01/2002
32Brain Ischemia (Cerebral Ischemia)
03/2022 - 10/2005
32Adenocarcinoma
02/2022 - 02/2002
32Heart Failure
01/2022 - 01/2003
31Adenocarcinoma of Lung
02/2022 - 05/2003
31Lymphatic Metastasis
01/2022 - 03/2002
31Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 10/2007
31Squamous Cell Carcinoma of Head and Neck
10/2021 - 09/2005

Drug/Important Bio-Agent (IBA)

553Proteins (Proteins, Gene)FDA Link
11/2022 - 02/2002
245Biomarkers (Surrogate Marker)IBA
12/2022 - 05/2004
223Pharmaceutical PreparationsIBA
07/2022 - 02/2002
164Messenger RNA (mRNA)IBA
08/2022 - 04/2002
150CytokinesIBA
08/2022 - 09/2003
140MicroRNAs (MicroRNA)IBA
04/2022 - 01/2010
121Biological ProductsIBA
12/2022 - 01/2003
93Long Noncoding RNAIBA
01/2022 - 01/2016
90DNA (Deoxyribonucleic Acid)IBA
04/2022 - 10/2002
88EnzymesIBA
01/2022 - 02/2003
86Glucose (Dextrose)FDA LinkGeneric
12/2022 - 05/2002
77VaccinesIBA
02/2022 - 08/2003
71AntigensIBA
05/2022 - 05/2003
67Small Interfering RNA (siRNA)IBA
01/2022 - 09/2006
65Therapeutic UsesIBA
06/2022 - 12/2002
62LipidsIBA
10/2022 - 05/2002
62RNA (Ribonucleic Acid)IBA
01/2022 - 09/2003
58Peptides (Polypeptides)IBA
12/2022 - 01/2005
57Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2005
57Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2002
56Phosphotransferases (Kinase)IBA
12/2022 - 05/2002
53Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 06/2003
51Transcription Factors (Transcription Factor)IBA
11/2022 - 04/2005
49CateninsIBA
06/2022 - 10/2011
49LigandsIBA
01/2022 - 01/2004
47CollagenIBA
08/2022 - 11/2004
46Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 01/2002
46Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2002
45AntioxidantsIBA
11/2022 - 08/2003
41Insulin (Novolin)FDA Link
08/2022 - 05/2002
40Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 08/2010
40Indicators and Reagents (Reagents)IBA
01/2022 - 04/2002
36Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 07/2004
35AntibodiesIBA
06/2022 - 04/2003
35Hormones (Hormone)IBA
05/2022 - 09/2006
34LipopolysaccharidesIBA
03/2022 - 07/2002
33AcidsIBA
06/2022 - 01/2003
32NF-kappa B (NF-kB)IBA
05/2022 - 02/2005
32Tyrosine Kinase InhibitorsIBA
02/2022 - 12/2010
32CalciumIBA
01/2022 - 10/2005

Therapy/Procedure

550Therapeutics
12/2022 - 01/2002
159Drug Therapy (Chemotherapy)
08/2022 - 11/2002
74Radiotherapy
03/2022 - 11/2003
73Immunotherapy
11/2022 - 07/2003
44Transplantation
01/2022 - 06/2003
36Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2021 - 02/2007
32Stents
05/2022 - 11/2005
32Aftercare (After-Treatment)
01/2022 - 02/2002